America is slimming down — one shot at a time. The number of US adults turning to blockbuster GLP-1 drugs like Ozempic and Wegovy for weight loss has hit a record high, nearly quadrupling in just two ...

Insurance coverage just changed for as many as 56 million Americans when it comes to the popular GLP-1 medications used to ...

Novo Nordisk launched oral Wegovy in the U.S. in January. The drug was an instant hit and has maintained strong momentum ...

Orlistat and Zepbound are two U.S. Food and Drug Administration (FDA)-approved weight loss medications that work in different ...

Zepbound and Trulicity are two U.S. Food and Drug Administration (FDA)-approved medications. When used alongside diet and ...

Welcome to Goodwin’s ERISA Litigation Update. Litigation involving ERISA-governed benefits plans has exploded in recent years ...

Potential signs of frailty in older adults taking Eli Lilly’s GLP-1 obesity drug Zepbound ​may signal relatively high risks ...

She soon realized getting it back was not straightforward. Deborah Finley, 50, of Lodi, California, said her weight started ...

The weight-loss drug is approved to treat obstructive sleep apnea, but some types of patients seem to benefit the most.

Federal regulators have agreed to review a Swiss pharmaceutical company's applications for two cheaper generic versions of ...

The federal government has launched a new program to make GLP-1 weight loss drugs more affordable for older Americans.

A professional in-home caregiver lost her coverage for Zepbound. She soon realized getting it back was not straightforward. “I was like: ‘What am I going to do? Hopefully I can just continue keeping ...